Evidence map›Paper›PMID 38924459›Full record

ReviewCancer research2024

Patterns of Aneuploidy and Signaling Consequences in Cancer.

Nadja Zhakula-Kostadinova, Alison M Taylor

Abstract readReview
In one paragraph

Review in Cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Mapping the genetic landscape of hereditary diffuse-type gastric cancer progression.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Investigating the Consequences of Aneuploidy in Cancer and Normal Tissue.Advances in experimental medicine and biology · 2026
    Review
  13. Article
  14. Article
  15. Review
  16. Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nadja Zhakula-KostadinovaHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0001-7205-230X
Alison M TaylorHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0001-9341-535X

Funding

Functional Understanding of Chromosome Arm AneuploidiesR35GM147287 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Alison M. Taylor · 2022 to 2026
$2.0M
Elucidating the Consequences of Chromosome 3 Arm Aneuploidies in Squamous Cell CarcinomaR01CA273723 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Alison M. Taylor · 2023 to 2026
$1.5M
Genomics of Renal Cancer in Patients of African AncestryR21CA280577 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI TAYLOR, ALISON M., ZHANG, JIAN · 2023 to 2024
$456k
National Cancer Institute (NCI) 1 R01 CA273723-01A1National Institute of General Medical Sciences (NIGMS) 5 R35 GM147287-02NCI NIH HHS R01 CA273723NCI NIH HHS R21 CA280577NIGMS NIH HHS R35 GM147287
6 · The paper itself

Abstract

Aneuploidy, or a change in the number of whole chromosomes or chromosome arms, is a near-universal feature of cancer. Chromosomes affected by aneuploidy are not random, with observed cancer-specific and tissue-specific patterns. Recent advances in genome engineering methods have allowed the creation of models with targeted aneuploidy events. These models can be used to uncover the downstream effects of individual aneuploidies on cancer phenotypes including proliferation, apoptosis, metabolism, and immune signaling. Here, we review the current state of research into the patterns of aneuploidy in cancer and their impact on signaling pathways and biological processes.

Indexed as

AneuploidyNeoplasmsSignal TransductionAnimalsHumans

Identifiers

PMID38924459
PMCPMC11325152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.